NLRP3 and type 2 diabetes mellitus: Henriksbo et al. revealed that Fluvastatin provokes inflammation and insulin resistance in adipose tissue via the upregulation of NLRP3, which is consistent with the increased expression of NLRP3 in inflamed adipose tissues of T2DM patients [192].